Option Care Health, Inc. (NASDAQ:OPCH – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six analysts that are currently covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $30.83.
OPCH has been the subject of a number of research analyst reports. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their price target for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Bank of America lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and cut their price target for the stock from $43.00 to $29.00 in a research note on Wednesday, October 30th. Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and decreased their price objective for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. Truist Financial cut their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. Finally, Barrington Research reduced their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a report on Thursday, October 31st.
Get Our Latest Stock Report on Option Care Health
Insider Transactions at Option Care Health
Hedge Funds Weigh In On Option Care Health
Several institutional investors have recently bought and sold shares of OPCH. Blue Trust Inc. boosted its holdings in shares of Option Care Health by 14.8% in the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after acquiring an additional 377 shares in the last quarter. GAMMA Investing LLC boosted its holdings in Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after purchasing an additional 471 shares in the last quarter. Lindenwold Advisors INC increased its position in Option Care Health by 5.4% during the 3rd quarter. Lindenwold Advisors INC now owns 9,548 shares of the company’s stock worth $299,000 after purchasing an additional 489 shares during the period. Trust Point Inc. raised its stake in shares of Option Care Health by 2.6% during the 3rd quarter. Trust Point Inc. now owns 24,124 shares of the company’s stock worth $755,000 after buying an additional 622 shares in the last quarter. Finally, Orion Portfolio Solutions LLC lifted its holdings in shares of Option Care Health by 2.3% in the 3rd quarter. Orion Portfolio Solutions LLC now owns 28,232 shares of the company’s stock valued at $884,000 after buying an additional 636 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.
Option Care Health Trading Up 0.2 %
OPCH opened at $23.80 on Friday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health has a one year low of $21.39 and a one year high of $34.63. The company has a market cap of $4.05 billion, a P/E ratio of 20.00, a PEG ratio of 2.46 and a beta of 1.32. The business’s 50-day simple moving average is $26.84 and its 200-day simple moving average is $28.87.
About Option Care Health
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Recommended Stories
- Five stocks we like better than Option Care Health
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- How to Choose Top Rated Stocks
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- Profitably Trade Stocks at 52-Week Highs
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.